Sanofi Healthcare: Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in India
Multinational pharmaceutical company, Sanofi Healthcare announced on Wednesday that it has received authorisation from drug regulator Cen…
#France #FR #Europe #EU #Sanofi #bleedingdisorders #cdscoapproval #clinicaldevelopmentprogramme #Fitusiran #HaemophiliaA #HaemophiliaB #haemophiliatreatment #Qfitliatherapy #rarediseases #SanofiHealthcare
https://www.europesays.com/france/97753/